Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Axonal Transport and Local Translation of mRNA in Amyotrophic Lateral Sclerosis

Seiichi Nagano  1   2 , Toshiyuki Araki  2
Toshiyuki Araki  1
, editors.
In: Amyotrophic Lateral Sclerosis [Internet]. Brisbane (AU): Exon Publications; 2021 Jul 25. Chapter 5.
Affiliations
Free Books & Documents
Review

Axonal Transport and Local Translation of mRNA in Amyotrophic Lateral Sclerosis

Seiichi Nagano et al.
Free Books & Documents

Excerpt

Since neurons have long neurites, especially axons, the transport of essential mRNAs, and their translation locally in axons, are essential to maintain the shape and function of the neurons. The RNA-binding protein TDP-43 (transactive response DNA binding protein 43) plays a crucial role in the transport and translation of mRNAs in neurons. In amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), TDP-43 and other RNA-binding proteins are mis-localized and abnormally deposited in neurons. Mutations of genes regulating these proteins have been identified in clinical cases. Impaired mRNA transport system may be a contributing factor of neurodegeneration in ALS/FTLD. In this chapter, we outline the role of RNA-binding proteins, with emphasis on TDP-43, in axonal transport and local translation of mRNAs in ALS/FTLD.

PubMed Disclaimer

References

    1. Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: Where are we now? Front Neurosci. 2019;13:1310. https://doi.org/10.3389/fnins.2019.01310 . - DOI - PMC - PubMed
    1. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602–11. https://doi.org/10.1016/j.bbrc.2006.10.093 . - DOI - PubMed
    1. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–3. https://doi.org/10.1126/science.1134108 . - DOI - PubMed
    1. Kattuah W, Rogelj B, King A, Shaw CE, Hortobágyi T, Troakes C. Heterogeneous nuclear ribonucleoprotein E2 (hnRNP E2) is a component of TDP-43 aggregates specifically in the A and C pathological subtypes of frontotemporal lobar degeneration. Front Neurosci. 2019;13:551. https://doi.org/10.3389/fnins.2019.00551 . - DOI - PMC - PubMed
    1. Gami-Patel P, Bandopadhyay R, Brelstaff J, Revesz T, Lashley T. The presence of heterogeneous nuclear ribonucleoproteins in frontotemporal lobar degeneration with FUS-positive inclusions. Neurobiol Aging. 2016;46:192–203. https://doi.org/10.1016/j.neurobiolaging.2016.07.004 . - DOI - PubMed

LinkOut - more resources